Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTPN7 | P35236 | 5/20 | 0.70 |
| ▸ | TERT | O14746 | 3/20 | 0.70 |
| ▸ | PTPN1 | P18031 | 3/20 | 0.70 |
| ▸ | PPARG | P37231 | 3/20 | 0.70 |
| ▸ | PPARD | Q03181 | 3/20 | 0.70 |
| ▸ | PPARA | Q07869 | 3/20 | 0.70 |
| ▸ | HMGCR | P04035 | 3/20 | 0.70 |
| ▸ | MAPT | P10636 | 2/20 | 0.70 |
| ▸ | BLM | P54132 | 2/20 | 0.70 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.70 |
| ▸ | FABP4 | P15090 | 2/20 | 0.70 |
| ▸ | F7 | P08709 | 2/20 | 0.70 |
| ▸ | F3 | P13726 | 2/20 | 0.70 |
| ▸ | DUSP3 | P51452 | 2/20 | 0.70 |
| ▸ | GMNN | O75496 | 1/20 | 0.70 |
| ▸ | USP2 | O75604 | 1/20 | 0.70 |
| ▸ | LMNA | P02545 | 1/20 | 0.70 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.70 |
| ▸ | POLB | P06746 | 1/20 | 0.70 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.70 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1371369 | 1.00 | PTPN7 (0.70) | PTPN7TERTPTPN1PPARGPPARD | |
| SCHEMBL1738166 | 1.00 | PTPN7 (0.70) | PTPN7TERTPTPN1PPARGPPARD | |
| SCHEMBL27039218 | 1.00 | PTPN7 (0.70) | PTPN7TERTPTPN1PPARGPPARD | |
| SCHEMBL269350 | 1.00 | PTPN7 (0.70) | PTPN7TERTPTPN1PPARGPPARD | |
| SCHEMBL1374586 | 1.00 | PTPN7 (0.70) | PTPN7TERTPTPN1PPARGPPARD | |
| SCHEMBL269349 | 1.00 | PTPN7 (0.70) | PTPN7TERTPTPN1PPARGPPARD | |
| SCHEMBL1374589 | 1.00 | PTPN7 (0.70) | PTPN7TERTPTPN1PPARGPPARD | |
| SCHEMBL10918369 | 0.95 | PTPN7 (0.67) | PTPN7TERTPTPN1PPARGPPARD | |
| SCHEMBL7594655 | 0.94 | PPARG (0.71) | PTPN7TERTPTPN1PPARGPPARD | |
| SCHEMBL7589866 | 0.94 | PPARG (0.71) | PTPN7TERTPTPN1PPARGPPARD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 463 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250354174-A1 | NANOPARTICLE COMPOSITIONS CONTAINING SUGAR FUNCTIONALIZED NUCLEIC ACID CARRIERS | TIBA BIOTECH LLC (US) | 2025-11-20 | — | — | US | claimed |
| EP-4638560-A1 | METHOD FOR PREPARING A THERMOSETTING BINDER COMPOSITION BASED ON WATER-SOLUBLE OR WATER-DISPERSIBLE LIGNIN ESTER, FOR BINDING FIBRES | Saint-Gobain Isover (FR) | 2025-10-29 | — | — | EP | claimed |
| US-12410448-B2 | Nanoparticle compositions containing sugar functionalized nucleic acid carriers | TIBA BIOTECH LLC (US) | 2025-09-09 | — | — | US | claimed |
| WO-2024134092-A1 | METHOD FOR PREPARING A THERMOSETTING BINDER COMPOSITION BASED ON WATER-SOLUBLE OR WATER-DISPERSIBLE LIGNIN ESTER, FOR BINDING FIBRES | SAINT-GOBAIN ISOVER (FR) | 2024-06-27 | — | — | WO | claimed |
| EP-4387607-A1 | NANOPARTICLE COMPOSITIONS CONTAINING SUGAR FUNCTIONALIZED NUCLEIC ACID CARRIERS | Tiba Biotech LLC (US) | 2024-06-26 | — | — | EP | claimed |
| US-20240093238-A1 | NANOPARTICLE COMPOSITIONS CONTAINING SUGAR FUNCTIONALIZED NUCLEIC ACID CARRIERS | TIBA BIOTECH LLC (US) | 2024-03-21 | — | — | US | claimed |
| US-11859201-B2 | Nanoparticle compositions containing sugar functionalized nucleic acid carriers | TIBA BIOTECH LLC (US) | 2024-01-02 | — | — | US | claimed |
| CN-116660543-A | Diagnostic and prognostic markers for nonalcoholic fatty liver disease and uses thereof | 中国人民解放军陆军军医大学第一附属医院 | 2023-08-29 | — | — | CN | claimed |
| US-20230100837-A1 | NANOPARTICLE COMPOSITIONS CONTAINING SUGAR FUNCTIONALIZED NUCLEIC ACID CARRIERS | TIBA BIOTECH LLC (US) | 2023-03-30 | — | — | US | claimed |
| WO-2023022926-A1 | NANOPARTICLE COMPOSITIONS CONTAINING SUGAR FUNCTIONALIZED NUCLEIC ACID CARRIERS | TIBA BIOTECH LLC (US) | 2023-02-23 | — | — | WO | claimed |
| US-20040121979-A1 | Pharmaceutically active uridine esters | TROMMSDORFF GMBH & CO. KG ARZNEIMITTEL (DE) | 2004-06-24 | — | — | US | claimed |
| CN-1505636-A | Pharmaceutically active uridine esters | ����ķ˹�ลҩ���ɷ�����˾������ | 2004-06-16 | — | — | CN | claimed |
| EP-1390378-A1 | PHARMACEUTICALLY ACTIVE URIDINE ESTERS | Trommsdorff GmbH & Co. KG Arzneimittel (DE) | 2004-02-25 | — | — | EP | claimed |
| EP-0889970-B1 | NOVEL PLANT ENZYME AND USE THEREOF | BAFOR MAUREEN (NG) | 2003-10-29 | — | — | EP | claimed |
| EP-1297156-A2 | METHODS FOR REGULATING BETA-OXIDATION IN PLANTS | PIONEER HI-BRED INTERNATIONAL, INC. (US) | 2003-04-02 | — | — | EP | claimed |
| WO-2002088159-A1 | PHARMACEUTICALLY ACTIVE URIDINE ESTERS | TROMMSDORFF GMBH & CO. KG ARZNEIMITTEL (DE) | 2002-11-07 | — | — | WO | claimed |
| US-20020078475-A1 | Methods for regulating beta-oxidation in plants | PIONEER HI-BRED INTERNATIONAL, INC. | 2002-06-20 | — | — | US | claimed |
| WO-2002004648-A2 | METHODS FOR REGULATING BETA-OXIDATION IN PLANTS | PIONEER HI-BRED INTERNATIONAL, INC. (US) | 2002-01-17 | — | — | WO | claimed |
| EP-0889970-A1 | NOVEL PLANT ENZYME AND USE THEREOF | Bafor, Maureen (NG) | 1999-01-13 | — | — | EP | claimed |
| WO-1997037033-A1 | NOVEL PLANT ENZYME AND USE THEREOF | BAFOR MAUREEN (NG) | 1997-10-09 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250354174-A1 | NANOPARTICLE COMPOSITIONS CONTAINING SUGAR FUNCTIONALIZED NUCLEIC ACID CARRIERS | TLR9, TLR3, TSG101 | PTPN7 732/4885TERT 2332/4885PTPN1 753/4885 |
| US-20230100837-A1 | NANOPARTICLE COMPOSITIONS CONTAINING SUGAR FUNCTIONALIZED NUCLEIC ACID CARRIERS | TLR9, TLR3, TSG101 | PTPN7 732/4885TERT 2332/4885PTPN1 753/4885 |
| US-20040121979-A1 | Pharmaceutically active uridine esters | UMPS, UGDH, FFAR1 | PTPN7 4353/4885TERT 1854/4885PTPN1 4416/4885 |
| US-20240093238-A1 | NANOPARTICLE COMPOSITIONS CONTAINING SUGAR FUNCTIONALIZED NUCLEIC ACID CARRIERS | TLR9, TLR3, TSG101 | PTPN7 732/4885TERT 2332/4885PTPN1 753/4885 |
| US-12410448-B2 | Nanoparticle compositions containing sugar functionalized nucleic acid carriers | TLR9, TLR3, TSG101 | PTPN7 732/4885TERT 2332/4885PTPN1 753/4885 |
| US-11859201-B2 | Nanoparticle compositions containing sugar functionalized nucleic acid carriers | TLR9, TLR3, TSG101 | PTPN7 732/4885TERT 2332/4885PTPN1 753/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.